Peter Bastien
Partner @ Hitachi Ventures
Boston, United States
Peter Bastien is a Series A investor at Hitachi Ventures in Boston focused on Supply Chain Management and B2B. Pete Bastien is a Partner at Hitachi Ventures.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Peter Bastien invests in
Stages Peter Bastien invests in
Countries Peter Bastien invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Supply Chain Management 2 (50%)
- B2B 1 (25%)
- Hardware 1 (25%)
- Robotics 1 (25%)
- Software 1 (25%)
Stage
- Series A 3 (75%)
- Seed 1 (25%)
Country
- Germany 1 (25%)
- Australia 1 (25%)
- United States 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Amplio enables you to reclaim control of your supply chain by making sourcing more cost-effective. | $11.1M / Series A / Sep 24, 2025 | ||
| Provectus Algae is a biotechnology company specializing in the optimization of microalgae species to produce high-value biobased chemicals, specialty ingredients, and biologics for use in a wide array of industries and applications. Provectus Algae enables groundbreaking capabilities with a well-balanced fusion of innovative proprietary technologyand a thorough knowledge of the unique biological traits of microalgae. By leveraging advanced automation, machine learning, and synthetic biology approaches, Provectus Algae can rapidly develop, execute, and license biomanufacturing processes depending on the needs of our commercial partners.Microalgae biotechnology holds tremendous potential for countless industries and products, thanks to microalgae’s impressive biochemical diversity, sophisticated biosynthesis machinery, and rapid growth rates, among other functional attributes. Importantly, photosynthetic microalgae species can also turn CO2 into valuable and in-demand biomolecules, providing the life science community with a powerful mechanism for adopting more sustainable biomanufacturing processes and reducing carbon footprint.Provectus Algae has built an end-to-end biomanufacturing platform capable of taking microalgae-based products from discovery to large-scale production, actualizing the full potential of microalgae biotechnology. We have brought together the combined strengths of our talented multidisciplinary team to rapidly build scalable microalgae production systems and source high-value compounds for our partners in the food and beverage, cosmetic, therapeutic, and agricultural industries. | $10.1M / Series A / Jul 22, 2025 | ||
| Provectus Algae is a biotechnology company specializing in the optimization of microalgae species to produce high-value biobased chemicals, specialty ingredients, and biologics for use in a wide array of industries and applications. Provectus Algae enables groundbreaking capabilities with a well-balanced fusion of innovative proprietary technologyand a thorough knowledge of the unique biological traits of microalgae. By leveraging advanced automation, machine learning, and synthetic biology approaches, Provectus Algae can rapidly develop, execute, and license biomanufacturing processes depending on the needs of our commercial partners.Microalgae biotechnology holds tremendous potential for countless industries and products, thanks to microalgae’s impressive biochemical diversity, sophisticated biosynthesis machinery, and rapid growth rates, among other functional attributes. Importantly, photosynthetic microalgae species can also turn CO2 into valuable and in-demand biomolecules, providing the life science community with a powerful mechanism for adopting more sustainable biomanufacturing processes and reducing carbon footprint.Provectus Algae has built an end-to-end biomanufacturing platform capable of taking microalgae-based products from discovery to large-scale production, actualizing the full potential of microalgae biotechnology. We have brought together the combined strengths of our talented multidisciplinary team to rapidly build scalable microalgae production systems and source high-value compounds for our partners in the food and beverage, cosmetic, therapeutic, and agricultural industries. | $11.4M / Seed / Dec 14, 2021 | ||
| ClearOps is a firm that provides B2B supply chain software for data-driven supply chain optimisation in the machine manufacturing industry. | $10M / Series A |
Co-Investors
About Hitachi Ventures
Hitachi Ventures invests in innovative companies that address society’s key technological challenges in areas like IT, industrial automation (robotics, sensor technology and IoT), cloud services (data management, cybersecurity), mobility (autonomous driving, mobility services, smart infrastructure and security services), energy, smart medicine (AIfor digital imaging, smart diagnostics, remote care), smart city, smart infrastructure and more. With our first fund of USD 150M, we invest in Series A/B/C rounds in globally leading startups. From our offices in Munich, Germany, and Boston, USA, we work tirelessly to develop close ties and effective collaboration with leading innovative technology hubs and like-minded co-investors. Hitachi intends to leverage its strong position in multiple global technology markets, its expertise and network to support and promote Hitachi Ventures portfolio companies.
Hitachi Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Joanna Soroka
Principal
|
|||
|
Peter Bastien
Partner
|
|||
Stefan Gabriel
Founder, MD and CEO
|
|||
Tobias Jahn
Partner
|
|||
Wolfgang Seibold
Partner & CFO
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Peter Bastien invest in?
Peter Bastien invests primarily in Supply Chain Management, B2B and Hardware startups, most often at Series A and Seed stage. Most of the 4 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Peter Bastien?
Public channels for Peter Bastien include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Peter Bastien last invest?
The most recent investment recorded for Peter Bastien closed in Sep 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
